Unknown

Dataset Information

0

Hydrogels derived from central nervous system extracellular matrix.


ABSTRACT: Biologic scaffolds composed of extracellular matrix (ECM) are commonly used repair devices in preclinical and clinical settings; however the use of these scaffolds for peripheral and central nervous system (CNS) repair has been limited. Biologic scaffolds developed from brain and spinal cord tissue have recently been described, yet the conformation of the harvested ECM limits therapeutic utility. An injectable CNS-ECM derived hydrogel capable of in vivo polymerization and conformation to irregular lesion geometries may aid in tissue reconstruction efforts following complex neurologic trauma. The objectives of the present study were to develop hydrogel forms of brain and spinal cord ECM and compare the resulting biochemical composition, mechanical properties, and neurotrophic potential of a brain derived cell line to a non-CNS-ECM hydrogel, urinary bladder matrix. Results showed distinct differences between compositions of brain ECM, spinal cord ECM, and urinary bladder matrix. The rheologic modulus of spinal cord ECM hydrogel was greater than that of brain ECM and urinary bladder matrix. All ECMs increased the number of cells expressing neurites, but only brain ECM increased neurite length, suggesting a possible tissue-specific effect. All hydrogels promoted three-dimensional uni- or bi-polar neurite outgrowth following 7 days in culture. These results suggest that CNS-ECM hydrogels may provide supportive scaffolding to promote in vivo axonal repair.

SUBMITTER: Medberry CJ 

PROVIDER: S-EPMC3512573 | biostudies-literature | 2013 Jan

REPOSITORIES: biostudies-literature

altmetric image

Publications


Biologic scaffolds composed of extracellular matrix (ECM) are commonly used repair devices in preclinical and clinical settings; however the use of these scaffolds for peripheral and central nervous system (CNS) repair has been limited. Biologic scaffolds developed from brain and spinal cord tissue have recently been described, yet the conformation of the harvested ECM limits therapeutic utility. An injectable CNS-ECM derived hydrogel capable of in vivo polymerization and conformation to irregul  ...[more]

Similar Datasets

| S-EPMC6597191 | biostudies-literature
| S-EPMC6797749 | biostudies-literature
| S-EPMC8004938 | biostudies-literature
| S-EPMC6471445 | biostudies-literature
| S-EPMC8950604 | biostudies-literature
| S-EPMC5669554 | biostudies-literature
| S-EPMC3322260 | biostudies-literature
2015-07-16 | PXD001285 | Pride
| S-EPMC8283909 | biostudies-literature
| S-EPMC6593768 | biostudies-literature